News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
381,009 Results
Type
Article (22128)
Company Profile (105)
Press Release (358776)
Section
Business (113178)
Career Advice (869)
Deals (19309)
Drug Delivery (81)
Drug Development (50694)
Employer Resources (85)
FDA (8898)
Job Trends (8623)
News (196691)
Policy (18445)
Tag
Academia (1214)
Alliances (28686)
Alzheimer's disease (596)
Approvals (8923)
Artificial intelligence (111)
Bankruptcy (173)
Best Places to Work (6605)
Breast cancer (109)
Cancer (859)
Cardiovascular disease (81)
Career advice (719)
Cell therapy (154)
Clinical research (41622)
Collaboration (338)
Compensation (123)
COVID-19 (1227)
C-suite (99)
Data (899)
Diabetes (112)
Diagnostics (2824)
Drug pricing (78)
Earnings (41383)
Employer resources (74)
Events (58547)
Executive appointments (366)
FDA (9360)
Funding (237)
Gene therapy (129)
GLP-1 (403)
Government (2116)
Healthcare (8886)
Infectious disease (1269)
Inflammatory bowel disease (71)
Interviews (98)
IPO (7951)
Job creations (2325)
Job search strategy (662)
Layoffs (209)
Legal (4257)
Lung cancer (132)
Manufacturing (148)
Medical device (4486)
Medtech (4490)
Mergers & acquisitions (11552)
Metabolic disorders (292)
Neuroscience (788)
NextGen: Class of 2025 (3316)
Non-profit (2674)
Northern California (917)
Obesity (154)
Opinion (140)
Patents (96)
People (36614)
Phase I (11400)
Phase II (17740)
Phase III (15211)
Pipeline (378)
Policy (75)
Postmarket research (1940)
Preclinical (5117)
Radiopharmaceuticals (143)
Rare diseases (190)
Real estate (3281)
Regulatory (13014)
Research institute (1126)
Resumes & cover letters (142)
Southern California (859)
Startups (1926)
United States (8695)
Vaccines (239)
Weight loss (109)
Date
Last 7 days (306)
Last 30 days (1283)
Last 365 days (18039)
2025 (2263)
2024 (18367)
2023 (21031)
2022 (29796)
2021 (31148)
2020 (29681)
2019 (25312)
2018 (19599)
2017 (18685)
2016 (18282)
2015 (21174)
2014 (16807)
2013 (14106)
2012 (15308)
2011 (16158)
2010 (14865)
Location
Africa (422)
Arizona (70)
Asia (24791)
Australia (3488)
California (2121)
Canada (1046)
China (239)
Colorado (91)
Connecticut (88)
Delaware (77)
Europe (50451)
Florida (387)
Illinois (262)
Indiana (158)
Japan (86)
Maryland (356)
Massachusetts (1634)
Michigan (72)
Minnesota (133)
New Jersey (811)
New York (605)
North Carolina (475)
Northern California (917)
Pennsylvania (491)
South America (782)
Southern California (859)
Texas (283)
Virginia (81)
Washington State (180)
381,009 Results for "kowa pharmaceuticals america".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arcutis Announces ZORYVE® U.S. Co-promote Agreement with Kowa Pharmaceuticals America, Inc.
July 29, 2024
·
7 min read
Business
Nicox and Kowa Enter into Agreement for NCX 470 Development and Commercialization in Japan
Nicox SA announced the signature of an agreement granting Kowa Company, Ltd., a Japanese company with a global pharmaceutical business engaged in ground-breaking research, development and marketing, exclusive Japanese rights to develop and commercialize NCX 470, Nicox’s nitric oxide (NO)-donating bimatoprost eye drop, for the lowering of intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.
February 8, 2024
·
5 min read
Press Releases
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America’s Most Successful Mid-Cap Companies
January 23, 2025
·
3 min read
Press Releases
Bio-Thera Solutions Announces Exclusive Commercialization and License Agreement with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), in the United States of America
February 10, 2025
·
6 min read
Drug Development
Kowa Pharmaceuticals America,Inc. Announces Publication of Phase 3 Data Supporting FDA Approval of SEGLENTIS®
Kowa Pharmaceuticals America,Inc. Announces Publication of Phase 3 Data Supporting FDA Approval of SEGLENTIS ® (celecoxib 56-mg and tramadol hydrochloride 44mg)CI-V as an Efficacious Alternative for Moderate-to-Severe Acute Pain in Appropriate Patients.
July 19, 2022
·
27 min read
Press Releases
Chris Rombach appointed President of Asahi Kasei Bioprocess America
February 19, 2025
·
4 min read
BioCapital
Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) announced today that management will participate in a fireside chat at the 2024 Bank of America Healthcare Conference on Wednesday, May 15, 2024, at 8:55 a.m. PT (11:55 a.m. ET).
May 8, 2024
·
1 min read
Genetown
Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America Securities Healthcare Conference
Apellis Pharmaceuticals, Inc. announced that the company will host a fireside chat at the Bank of America Securities Healthcare Conference on Tuesday, May 14, 2024, at 8:00 a.m. PT.
May 6, 2024
·
1 min read
Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference
Kiniksa Pharmaceuticals, Ltd. announced that management will participate in a fireside chat at the Bank of America Securities 2024 Healthcare Conference on Tuesday, May 14, 2024 at 10:40 a.m. Pacific Time.
May 7, 2024
·
1 min read
Biotech Bay
Ultragenyx to Participate at Bank of America’s 2024 Healthcare Conference
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that Eric Crombez, M.D., the company’s chief medical officer and executive vice president, will participate in a fireside at Bank of America’s 2024 Healthcare Conference on Tuesday, May 14, 2024, at 1:40 p.m. PT.
May 7, 2024
·
1 min read
1 of 38,101
Next
